Cargando…
Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, emerged in late 2019 in Wuhan, China. The World Health Organization declared the virus a pandemic on March 11, 2020. Disease progression from COVID-19 infection has shown significant symptom manifestations within o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919539/ https://www.ncbi.nlm.nih.gov/pubmed/34511231 http://dx.doi.org/10.1016/j.bpa.2021.02.003 |
_version_ | 1783658146780151808 |
---|---|
author | Kaye, Alan D. Spence, Allyson L. Mayerle, Mariah Sardana, Nitish Clay, Claire M. Eng, Matthew R. Luedi, Markus M. Carroll Turpin, Michelle A. Urman, Richard D. Cornett, Elyse M. |
author_facet | Kaye, Alan D. Spence, Allyson L. Mayerle, Mariah Sardana, Nitish Clay, Claire M. Eng, Matthew R. Luedi, Markus M. Carroll Turpin, Michelle A. Urman, Richard D. Cornett, Elyse M. |
author_sort | Kaye, Alan D. |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, emerged in late 2019 in Wuhan, China. The World Health Organization declared the virus a pandemic on March 11, 2020. Disease progression from COVID-19 infection has shown significant symptom manifestations within organ systems beyond the respiratory system. The literature has shown increasing evidence of cardiovascular involvement during disease course and an associated increase in mortality among infected patients. Although the understanding of this novel virus is continually evolving, it is currently proposed that the mechanism by which the SARS-CoV-2 virus contributes to cardiovascular manifestations involves the ACE2 transmembrane protein. The protein ACE2 is highly expressed in blood vessel pericytes, and infection can result in microvascular dysfunction and subsequent acute coronary syndromes. Complications involving the cardiovascular system include myocardial infarction, arrhythmias, shock, and heart failure. In this evidence-based review, we discuss risk factors of cardiovascular involvement in COVID-19 infection, pathophysiology of COVID-19-related cardiovascular infection, and injury, COVID-19 effects on the cardiovascular system and corresponding treatments, and hematologic effects of COVID-19 and COVID-19 in heart transplant patients. Clinicians managing COVID-19 patients should appreciate the potential cardiovascular effects related to the disease process. |
format | Online Article Text |
id | pubmed-7919539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79195392021-03-02 Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes Kaye, Alan D. Spence, Allyson L. Mayerle, Mariah Sardana, Nitish Clay, Claire M. Eng, Matthew R. Luedi, Markus M. Carroll Turpin, Michelle A. Urman, Richard D. Cornett, Elyse M. Best Pract Res Clin Anaesthesiol 13 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, emerged in late 2019 in Wuhan, China. The World Health Organization declared the virus a pandemic on March 11, 2020. Disease progression from COVID-19 infection has shown significant symptom manifestations within organ systems beyond the respiratory system. The literature has shown increasing evidence of cardiovascular involvement during disease course and an associated increase in mortality among infected patients. Although the understanding of this novel virus is continually evolving, it is currently proposed that the mechanism by which the SARS-CoV-2 virus contributes to cardiovascular manifestations involves the ACE2 transmembrane protein. The protein ACE2 is highly expressed in blood vessel pericytes, and infection can result in microvascular dysfunction and subsequent acute coronary syndromes. Complications involving the cardiovascular system include myocardial infarction, arrhythmias, shock, and heart failure. In this evidence-based review, we discuss risk factors of cardiovascular involvement in COVID-19 infection, pathophysiology of COVID-19-related cardiovascular infection, and injury, COVID-19 effects on the cardiovascular system and corresponding treatments, and hematologic effects of COVID-19 and COVID-19 in heart transplant patients. Clinicians managing COVID-19 patients should appreciate the potential cardiovascular effects related to the disease process. Elsevier Ltd. 2021-10 2021-03-01 /pmc/articles/PMC7919539/ /pubmed/34511231 http://dx.doi.org/10.1016/j.bpa.2021.02.003 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 13 Kaye, Alan D. Spence, Allyson L. Mayerle, Mariah Sardana, Nitish Clay, Claire M. Eng, Matthew R. Luedi, Markus M. Carroll Turpin, Michelle A. Urman, Richard D. Cornett, Elyse M. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes |
title | Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes |
title_full | Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes |
title_fullStr | Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes |
title_full_unstemmed | Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes |
title_short | Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes |
title_sort | impact of covid-19 infection on the cardiovascular system: an evidence-based analysis of risk factors and outcomes |
topic | 13 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919539/ https://www.ncbi.nlm.nih.gov/pubmed/34511231 http://dx.doi.org/10.1016/j.bpa.2021.02.003 |
work_keys_str_mv | AT kayealand impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT spenceallysonl impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT mayerlemariah impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT sardananitish impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT clayclairem impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT engmatthewr impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT luedimarkusm impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT carrollturpinmichellea impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT urmanrichardd impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes AT cornettelysem impactofcovid19infectiononthecardiovascularsystemanevidencebasedanalysisofriskfactorsandoutcomes |